Inovio Pharmaceuticals Pulls in $71M in Pentagon Funding
Thursday, July 2, 2020
Photo courtesy of Inovio. Pentagon funds are helping Inovio develop and produce its Cellectra devices, which delivers its vaccine under a patient’s skin. Shown is the Cellectra 3PSP model.
A company pursuing a DNA vaccine for COVID-19, Inovio Pharmaceuticals, received $71 million from the U...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know